Kyle Jenne
CIK 1791857 · EVP, Chf GL Pdt Str Ofcr · last filed 2026-04-17
Kyle Jenne is an EVP, Chf GL Pdt Str Ofcr who has filed 13 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing, for IONS, was dated Apr 17, 2026. Across all open-market trades the lifetime net is −$3.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.10M
2
13
-$3.44M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IONS | EVP, Chf GL Pdt Str Ofcr | 28,615 | $73.28 | $2.10M | -$3.42M | 8 | 2026-04-17 |
| AKCEA THERAPEUTICS, INC. (AKCA) Delisted | Chief Commercial Officer | 0 | — | — | -$22.2K | 5 | 2020-10-13 |
Recent Filings
13 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-17 | IONS | Mixed | +7,324 | -$368.5K | EDGAR |
| 2026-03-11 | IONS | Mixed | — | -$1.16M | EDGAR |
| 2026-01-20 | IONS | Mixed | +5,190 | -$138.5K | EDGAR |
| 2026-01-06 | IONS | Grant (A) | — | $0 | EDGAR |
| 2025-04-17 | IONS | Mixed | +9,210 | -$85.5K | EDGAR |
| 2025-01-17 | IONS | Grant (A) | — | $0 | EDGAR |
| 2025-01-06 | IONS | Grant (A) | — | $0 | EDGAR |
| 2024-03-13 | IONS | Grant (A) | — | $0 | EDGAR |
| 2020-10-13 | AKCEA THERAPEUTICS, INC. (AKCA) Delisted | Mixed | −52,012 | -$944.0K | EDGAR |
| 2020-09-24 | AKCEA THERAPEUTICS, INC. (AKCA) Delisted | Sell (S) | −720 | -$13.0K | EDGAR |